HCM
CRL icon

Hodges Capital Management’s Charles River Laboratories CRL Stock Holding History

Hodges Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-51,961
Closed -$5.69M – 249
2017
Q4 		$5.69M Sell
51,961
-35,995
-41% -$3.92M 0.42% 70
2017
Q3 		$9.5M Sell
87,956
-183,995
-68% -$18.9M 0.64% 51
2017
Q2 		$27.5M Buy
271,951
+2,150
+0.8% +$198K 1.63% 17
2017
Q1 		$24.3M Sell
269,801
-75,105
-22% -$6.38M 1.21% 26
2016
Q4 		$26.3M Sell
344,906
-38,380
-10% -$2.91M 1.21% 28
2016
Q3 		$31.9M Sell
383,286
-6,770
-2% -$568K 1.54% 22
2016
Q2 		$32.2M Sell
390,056
-2,710
-0.7% -$223K 1.56% 22
2016
Q1 		$29.8M Buy
392,766
+2,090
+0.5% +$155K 1.38% 22
2015
Q4 		$31.4M Buy
390,676
+1,706
+0.4% +$123K 1.31% 22
2015
Q3 		$24.7M Buy
388,970
+4,350
+1% +$312K 1.01% 40
2015
Q2 		$27.1M Buy
384,620
+169,710
+79% +$12.6M 0.98% 37
2015
Q1 		$17M Buy
+214,910
New +$15.9M 0.65% 67

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hodges Capital Management's CRL Position: Q1 2018 in Review

Hodges Capital Management sold out of Charles River Laboratories (CRL) in Q1 2018, closing a stake of 51,961 shares — an estimated $5.69M sold.

Hodges Capital Management first reported a position in CRL in Q1 2015 and held it in 12 quarters. The position peaked at $32.2M in Q2 2016. 333 funds tracked by Wall St. Rank hold CRL as of Q1 2018.

  • Hodges Capital Management reported no remaining Charles River Laboratories position as of Q1 2018 after selling out during the quarter.
  • Hodges Capital Management sold 51,961 Charles River Laboratories shares in Q1 2018, an estimated $5.69M.
  • Hodges Capital Management first reported a position in Charles River Laboratories in Q1 2015 and held it in 12 quarters.
  • Hodges Capital Management's Charles River Laboratories position peaked at $32.2M in Q2 2016.
  • 333 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2018.

Based on Hodges Capital Management's 13F filing for Q1 2018, filed 3 May 2018.